The Nifty Next 50 is a stock market index representing the 50 listed companies, which are next in line after the Nifty 50 in terms of market capitalization. It includes companies from various sectors, offering investors exposure to emerging and mid-cap stocks with growth potential.
The index serves as a good indicator for identifying promising companies that could be future Nifty 50 contenders. It’s a popular choice for those looking for higher growth opportunities beyond the established Nifty 50 stocks.
Investing in the Nifty Next 50 index offers exposure to a diversified group of emerging companies with high growth potential. As these companies are typically mid-cap, they have the potential to grow faster, making the index attractive for investors looking for higher returns. Additionally, the Nifty Next 50 acts as a stepping stone for companies that could eventually be part of the Nifty 50, adding to its long-term investment appeal.
Here are the three stocks that have given positive returns in the last six months.
Bajaj Holdings and Investments Limited
Bajaj Holdings and Investments Limited is a part of the Bajaj Group and primarily acts as an investment company. The company has significant stakes in companies like Bajaj Auto, Bajaj Finserv, and Bajaj Finance. With its diversified portfolio, Bajaj Holdings generates income from dividends, interest, and capital gains.
With a market capitalization of Rs. 1,32,439.28 crores on Friday, the company’s revenue rose by 19.4 percent from Rs. 132.5 crores to Rs. 158.23 crores in Q3FY24-25. Meanwhile, Net profit rose from Rs. 1,644.92 crore to Rs. 1,749.97 crore during the same period.
The company has given a 21 percent return in the last six months and a 254.7 percent return over the last five years and has a Sales CAGR of 32 percent and a Profit CAGR of 19 percent over the same period.
Shree Cement Limited
Shree Cement Limited is one of India’s leading cement manufacturers, known for its high-quality products and strong market presence. The company operates a wide network of cement plants and has a diversified product range, including ordinary Portland cement (OPC), blended cement, and ready-mix concrete (RMC).
With a market capitalization of Rs. 1,00,708.40 crores on Friday, the company’s revenue declined by 12.8 percent from Rs. 5,370.65 crores to Rs. 4,683.46 crores in Q3FY24-25. Meanwhile, Net profit declined from Rs. 701.89 crore to Rs. 193.4 crore during the same period.
The company has given a 13.69 percent return in the last six months and 21 percent in the last 5 years, and it has a Sales CAGR of 10 percent and a Profit CAGR of 16 percent over the same period.
Divis Laboratories Limited
Divis Laboratories Limited is a prominent Indian pharmaceutical company specializing in the manufacturing of active pharmaceutical ingredients (APIs) and intermediates. It is known for its expertise in the production of generic medicines and custom synthesis for global pharmaceutical companies.
With a market capitalization of Rs. 1,46,707.23 crores on Friday, the company’s revenue rose by 23.13 percent from Rs. 1,950 crores to Rs. 2,401 crores in Q3FY24-25. Meanwhile, Net profit rose from Rs. 358 crore to Rs. 589 crore during the same period.
The company has given a 10 percent return in the last six months and a 160 percent return over the last five years and has a Sales CAGR of 10 percent and a Profit CAGR of 3 percent over the same period.
Written by Sridhar J
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
